Madrigal Pharmaceuticals Inc
(MDGL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -143,121 | -85,158 | -36,135 | -83,948 | -56,208 |
| Depreciation Amortization | 355 | 240 | 125 | 112 | 84 |
| Accounts payable and accrued liabilities | 5,099 | 3,826 | -63 | -1,309 | -1,714 |
| Other Working Capital | 24,556 | 19,619 | 658 | 19,453 | 8,055 |
| Other Operating Activity | 10,497 | 6,709 | 4,909 | 24,068 | 20,441 |
| Operating Cash Flow | $-102,614 | $-54,764 | $-30,506 | $-41,624 | $-29,342 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 164,902 | 70,146 | 50,774 | 30,879 | 61,252 |
| PPE Investments | -324 | -321 | -314 | -172 | -38 |
| Investing Cash Flow | $164,578 | $69,825 | $50,460 | $30,707 | $61,214 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 459 | 109 | N/A | 235 | 235 |
| Financing Cash Flow | $459 | $109 | $N/A | $235 | $235 |
| Beginning Cash Position | 46,697 | 46,697 | 46,697 | 57,379 | 57,379 |
| End Cash Position | 109,120 | 61,867 | 66,651 | 46,697 | 89,486 |
| Net Cash Flow | $62,423 | $15,170 | $19,954 | $-10,682 | $32,107 |
| Free Cash Flow | |||||
| Operating Cash Flow | -102,614 | -54,764 | -30,506 | -41,624 | -29,342 |
| Capital Expenditure | -324 | -321 | -314 | -172 | -38 |
| Free Cash Flow | -102,938 | -55,085 | -30,820 | -41,796 | -29,380 |